The Alzheimer's Association workgroup, Participant FIRST, has released 17 recommendations for better communication with study participants and their partners when clinical trials end early. The recommendations include allocating sufficient resources for orderly closeout, regularly updating contact information, and ensuring that news releases explicitly address participants and study partners. The workgroup emphasizes the importance of clear communication and coordination among all parties involved in the trial.